Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Chase, A; Huntly, BJP; Cross, NCP
   Cytogenetics of chronic myeloid leukaemia
   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
   
   A. Chase et al., "Cytogenetics of chronic myeloid leukaemia", BEST P R C, 14(3), 2001, pp. 553-571
2. Moradpour, D; Cerny, A; Heim, MH; Blum, HE
   Hepatitis C: an update
   SWISS MEDICAL WEEKLY
   
   D. Moradpour et al., "Hepatitis C: an update", SWISS MED W, 131(21-22), 2001, pp. 291-298
3. Grahovac, B; Bingulac-Popovic, J; Vucelic, B; Hrstic, I; Ostojic, R; Drazic, V; Balija, M; Grgicevic, D
   Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C
   JOURNAL OF CLINICAL VIROLOGY
   
   B. Grahovac et al., "Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C", J CLIN VIRO, 20(1-2), 2001, pp. 85-89
4. Arase, Y; Ikeda, K; Chayama, K; Murashima, N; Tsubota, A; Suzuki, Y; Saitoh, S; Kobayashi, M; Kobayashi, M; Suzuki, F; Kumada, H
   Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration
   HEPATOLOGY RESEARCH
   
   Y. Arase et al., "Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration", HEPATOL RES, 19(1), 2001, pp. 22-30
5. Harcourt, G; Hellier, S; Bunce, M; Satsangi, J; Collier, J; Chapman, R; Phillips, R; Klenerman, P
   Effect of HLA class II genotype on T helper lymphocyte responses and viralcontrol in hepatitis C virus infection
   JOURNAL OF VIRAL HEPATITIS
   
   G. Harcourt et al., "Effect of HLA class II genotype on T helper lymphocyte responses and viralcontrol in hepatitis C virus infection", J VIRAL HEP, 8(3), 2001, pp. 174-179
6. Comanor, L; Minor, J; Conjeevaram, HS; Roberts, EA; Alvarez, F; Bern, EM; Goyens, P; Rosenthal, P; Lachaux, A; Shelton, M; Sarles, J; Sokal, EM
   Impact of chronic hepatitis B and interferon-alpha therapy on growth of children
   JOURNAL OF VIRAL HEPATITIS
   
   L. Comanor et al., "Impact of chronic hepatitis B and interferon-alpha therapy on growth of children", J VIRAL HEP, 8(2), 2001, pp. 139-147
7. Regina, S; Colombat, P; Fimbel, B; Guerois, C; Gruel, Y
   Acquired inhibitor to factor VIII in a patient with Hodgkin's disease following treatment with interferon-alpha
   HAEMOPHILIA
   
   S. Regina et al., "Acquired inhibitor to factor VIII in a patient with Hodgkin's disease following treatment with interferon-alpha", HAEMOPHILIA, 7(5), 2001, pp. 526-527
8. Koretz, RL
   Hepatitis C - The case against treatment
   EUROPEAN JOURNAL OF SURGERY
   
   R.L. Koretz, "Hepatitis C - The case against treatment", EURO J SURG, 167, 2001, pp. 34-39
9. Ko, WJ; Chou, NK; Hsu, RB; Chen, YS; Wang, SS; Chu, SH; Lai, MY
   Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area
   JOURNAL OF HEART AND LUNG TRANSPLANTATION
   
   W.J. Ko et al., "Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area", J HEART LUN, 20(8), 2001, pp. 865-875
10. Wang, YL; Bagg, A; Pear, W; Nowell, PC; Hess, JL
    Chronic myelogenous leukemia: Laboratory diagnosis and monitoring
    GENES CHROMOSOMES & CANCER
    
    Y.L. Wang et al., "Chronic myelogenous leukemia: Laboratory diagnosis and monitoring", GENE CHROM, 32(2), 2001, pp. 97-111
11. Kitzis, A; Brizard, F; Dascalescu, C; Chomel, JC; Guilhot, F; Brizard, A
    Persistence of transcriptionally silent BCR-ABL rearrangements in chronic myeloid leukemia patients in sustained complete cytogenetic remission
    LEUKEMIA & LYMPHOMA
    
    A. Kitzis et al., "Persistence of transcriptionally silent BCR-ABL rearrangements in chronic myeloid leukemia patients in sustained complete cytogenetic remission", LEUK LYMPH, 42(5), 2001, pp. 933
12. Gebhart, E; Rosler, W; Gramatzki, M; Trautmann, U
    FISH monitoring of 100 courses of human leukemias: The cytogenetic viewpoint
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    E. Gebhart et al., "FISH monitoring of 100 courses of human leukemias: The cytogenetic viewpoint", INT J ONCOL, 19(3), 2001, pp. 617-623
13. Ruocco, E; Aurilia, A; Ruocco, V
    Precautions and suggestions for pemphigus patients
    DERMATOLOGY
    
    E. Ruocco et al., "Precautions and suggestions for pemphigus patients", DERMATOLOGY, 203(3), 2001, pp. 201-207
14. Brook, MG
    European guideline for the management of hepatitis B and C virus infections
    INTERNATIONAL JOURNAL OF STD & AIDS
    
    M.G. Brook, "European guideline for the management of hepatitis B and C virus infections", INT J STD A, 12, 2001, pp. 48-57
15. Peck-Radosavljevic, M
    Hypersplenism
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    M. Peck-Radosavljevic, "Hypersplenism", EUR J GASTR, 13(4), 2001, pp. 317-323
16. Larson, AM; Carithers, RL
    Hepatitis C in clinical practice
    JOURNAL OF INTERNAL MEDICINE
    
    A.M. Larson e R.L. Carithers, "Hepatitis C in clinical practice", J INTERN M, 249(2), 2001, pp. 111-120
17. Par, A; Telegdy, L; Dalmi, L; Muller, E
    Therapy for chronic hepatitis C
    JOURNAL OF PHYSIOLOGY-PARIS
    
    A. Par et al., "Therapy for chronic hepatitis C", J PHYSL-PAR, 95(1-6), 2001, pp. 399-405
18. Obermayer-Straub, P; Manns, MP
    Hepatitis C and D, retroviruses and autoimmune manifestations
    JOURNAL OF AUTOIMMUNITY
    
    P. Obermayer-Straub e M.P. Manns, "Hepatitis C and D, retroviruses and autoimmune manifestations", J AUTOIMMUN, 16(3), 2001, pp. 275-285
19. Maes, M; Capuron, L; Ravaud, A; Gualde, N; Bosmans, E; Egyed, B; Dantzer, R; Neveu, PJ
    Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy
    NEUROPSYCHOPHARMACOLOGY
    
    M. Maes et al., "Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapy", NEUROPSYCH, 24(2), 2001, pp. 130-140
20. Payne, DA; Seifert, SL; Brody, BA
    Effects of storage and viral load on hepatitis C viral genotyping
    JOURNAL OF CLINICAL LABORATORY ANALYSIS
    
    D.A. Payne et al., "Effects of storage and viral load on hepatitis C viral genotyping", J CL LAB AN, 15(6), 2001, pp. 331-333
21. Pawlotsky, JM
    Virus of hepatitis C and immune response
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    
    J.M. Pawlotsky, "Virus of hepatitis C and immune response", GASTRO CL B, 25(4), 2001, pp. B123-B133
22. Couzigou, P; De Ledinghen, V; Foucher, J
    Chronic viral hepatitis C : current therapy and perspectives
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    
    P. Couzigou et al., "Chronic viral hepatitis C : current therapy and perspectives", GASTRO CL B, 25(4), 2001, pp. B135-B142
23. Pol, S; Fontaine, H; Vallet-Pichard, A
    Synopsis: Treatments for hepatitis virus C infections
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    
    S. Pol et al., "Synopsis: Treatments for hepatitis virus C infections", GASTRO CL B, 25(3), 2001, pp. 289-301
24. Fabrizi, F; Lunghi, G; Martin, P
    Treatment of HCV-related liver disease in the dialysis population: A novelchallenge for clinical nephrologists
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    
    F. Fabrizi et al., "Treatment of HCV-related liver disease in the dialysis population: A novelchallenge for clinical nephrologists", INT J ARTIF, 24(6), 2001, pp. 335-346
25. Classen, JB; Classen, DC
    Vaccines and the risk of insulin-dependent diabetes (IDDM): potential mechanism of action
    MEDICAL HYPOTHESES
    
    J.B. Classen e D.C. Classen, "Vaccines and the risk of insulin-dependent diabetes (IDDM): potential mechanism of action", MED HYPOTH, 57(5), 2001, pp. 532-538
26. Capuron, L; Ravaud, A; Gualde, N; Bosmans, E; Dantzer, R; Maes, M; Neveu, PJ
    Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy
    PSYCHONEUROENDOCRINOLOGY
    
    L. Capuron et al., "Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy", PSYCHONEURO, 26(8), 2001, pp. 797-808
27. Goobar-Larsson, L; Wiklund, L; Schwartz, S
    Intracellular hepatitis c virus RNA-dependent RNA polymerase activity
    ARCHIVES OF VIROLOGY
    
    L. Goobar-Larsson et al., "Intracellular hepatitis c virus RNA-dependent RNA polymerase activity", ARCH VIROL, 146(8), 2001, pp. 1553-1570
28. Chinchai, T; Noppornpanth, S; Theamboonlers, A; Chongsrisawat, V; Poovorawan, Y
    Acute posttransfusion hepatitis C: Identification of a common hepatitis C virus strain in donor and recipient using polymorphism analysis
    INFECTION
    
    T. Chinchai et al., "Acute posttransfusion hepatitis C: Identification of a common hepatitis C virus strain in donor and recipient using polymorphism analysis", INFECTION, 29(1), 2001, pp. 40-43
29. Markowitz, GS; Kaur, P; Orazi, A; Kambham, N; Cheng, JT; Prial, MM; Pogue, VA; D'Agati, VD
    A 51-year-old female with nephrotic syndrome, renal failure, and hepatitisC virus infection
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    G.S. Markowitz et al., "A 51-year-old female with nephrotic syndrome, renal failure, and hepatitisC virus infection", AM J KIDNEY, 37(2), 2001, pp. 442-447
30. Martinot-Peignoux, M; Boyer, N; Cazals-Hatem, D; Pham, BN; Gervais, A; Le Breton, V; Levy, S; Degott, C; Valla, DC; Marcellin, P
    Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA
    HEPATOLOGY
    
    M. Martinot-Peignoux et al., "Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA", HEPATOLOGY, 34(5), 2001, pp. 1000-1005
31. Calleja, JL; Albillos, A; Rossi, I; Moreno, R; Domper, F; Marinez, JL; Escartin, P
    Time course of serum hepatitis C virus-RNA during chronic hepatitis C treatment accurately predicts the type of response
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    
    J.L. Calleja et al., "Time course of serum hepatitis C virus-RNA during chronic hepatitis C treatment accurately predicts the type of response", ALIM PHARM, 15(2), 2001, pp. 241-249
32. Fontaine, H; Pol, S
    Prevention and treatment of viral hepatitis in renal failure
    NEPHROLOGIE
    
    H. Fontaine e S. Pol, "Prevention and treatment of viral hepatitis in renal failure", NEPHROLOGIE, 22(7), 2001, pp. 339-347
33. Bonnet, F; Dubuc, J; Morlat, P; Delbrel, X; Doutre, MS; de Witte, S; Bernard, N; Lacoste, D; Longy-Boursier, M; Beylot, J
    Sarcoidosis and associated illnesses. A 32-case retrospective study
    REVUE DE MEDECINE INTERNE
    
    F. Bonnet et al., "Sarcoidosis and associated illnesses. A 32-case retrospective study", REV MED IN, 22(7), 2001, pp. 619-623
34. Trotter, JF; Zygmunt, AJ
    Conception and pregnancy during interferon-alpha therapy for chronic hepatitis C
    JOURNAL OF CLINICAL GASTROENTEROLOGY
    
    J.F. Trotter e A.J. Zygmunt, "Conception and pregnancy during interferon-alpha therapy for chronic hepatitis C", J CLIN GAST, 32(1), 2001, pp. 76-78
35. English, JC; Patel, PJ; Greer, KE
    Sarcoidosis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
    
    J.C. English et al., "Sarcoidosis", J AM ACAD D, 44(5), 2001, pp. 725-743
36. Berenguer, M; Lopez-Labrador, FX; Wright, TL
    Hepatitis C and liver transplantation
    JOURNAL OF HEPATOLOGY
    
    M. Berenguer et al., "Hepatitis C and liver transplantation", J HEPATOL, 35(5), 2001, pp. 666-678
37. Gervais, A; Martinot, M; Boyer, N; Auperin, A; Le Breton, W; Degott, C; Valla, D; Marcellin, P
    Quantitation of hepatic hepatitis C virus RNA in patients with chronic hepatitis C. Relationship with severity of disease, viral genotype and response to treatment
    JOURNAL OF HEPATOLOGY
    
    A. Gervais et al., "Quantitation of hepatic hepatitis C virus RNA in patients with chronic hepatitis C. Relationship with severity of disease, viral genotype and response to treatment", J HEPATOL, 35(3), 2001, pp. 399-405
38. Andriulli, A; Festa, V; Leandro, G; Rizzetto, M
    Usefulness of a liver biopsy in the evaluation of patients with elevated ALT values and serological markers of hepatitis viral infection - An AIGO study
    DIGESTIVE DISEASES AND SCIENCES
    
    A. Andriulli et al., "Usefulness of a liver biopsy in the evaluation of patients with elevated ALT values and serological markers of hepatitis viral infection - An AIGO study", DIG DIS SCI, 46(7), 2001, pp. 1409-1415
39. Kurihara, C; Ishiyama, N; Nishiyama, Y; Fukushi, S; Kageyama, T; Katayama, K; Miura, S
    Molecular characterization of hepatitis C virus genotype 2a from the entire sequences of four isolates
    JOURNAL OF MEDICAL VIROLOGY
    
    C. Kurihara et al., "Molecular characterization of hepatitis C virus genotype 2a from the entire sequences of four isolates", J MED VIROL, 64(4), 2001, pp. 466-475
40. Toyoda, H; Kumada, T; Nakano, S; Takeda, I; Sugiyama, K; Kiriyama, S; Sone, Y; Hisanaga, Y
    Characteristics and course of small hepatocellular carcinomas in patients with hepatitis C virus types 1 and 2
    JOURNAL OF MEDICAL VIROLOGY
    
    H. Toyoda et al., "Characteristics and course of small hepatocellular carcinomas in patients with hepatitis C virus types 1 and 2", J MED VIROL, 63(2), 2001, pp. 120-127
41. Pisoni, R; Ruggenenti, P; Remuzzi, G
    Drug-induced thrombotic microangiopathy - Incidence, prevention and management
    DRUG SAFETY
    
    R. Pisoni et al., "Drug-induced thrombotic microangiopathy - Incidence, prevention and management", DRUG SAFETY, 24(7), 2001, pp. 491-501
42. Gervais, A; Boyer, N; Marcellin, P
    Tolerability of treatments for viral hepatitis
    DRUG SAFETY
    
    A. Gervais et al., "Tolerability of treatments for viral hepatitis", DRUG SAFETY, 24(5), 2001, pp. 375-384
43. Kintzel, PE
    Anticancer drug-induced kidney disorders - Incidence, prevention and management
    DRUG SAFETY
    
    P.E. Kintzel, "Anticancer drug-induced kidney disorders - Incidence, prevention and management", DRUG SAFETY, 24(1), 2001, pp. 19-38
44. Lin, OS; Keeffe, EB
    Current treatment strategies for chronic hepatitis B and C
    ANNUAL REVIEW OF MEDICINE
    
    O.S. Lin e E.B. Keeffe, "Current treatment strategies for chronic hepatitis B and C", ANN R MED, 52, 2001, pp. 29-49
45. Koukoulis, GK
    Chronic hepatitis C: Grading, staging, and searching for reliable predictors of outcome
    HUMAN PATHOLOGY
    
    G.K. Koukoulis, "Chronic hepatitis C: Grading, staging, and searching for reliable predictors of outcome", HUMAN PATH, 32(9), 2001, pp. 899-903
46. Keil, F; Mitterbauer, G; Chen, X; Haas, OA; Kalhs, P; Lechner, K; Mannhalter, C; Moser, K; Worel, N; Pirc-Danoewinata, H; Louda, N; Loidolt, H; Rabitsch, W; Greinix, HT
    PBPC mobilization with chemotherapy and G-CSF in patients with chronic myeloid leukemia: quantification of bcr/abl-positive cells by interphase fluorescence in situ hybridization and competitive PCR
    TRANSFUSION
    
    F. Keil et al., "PBPC mobilization with chemotherapy and G-CSF in patients with chronic myeloid leukemia: quantification of bcr/abl-positive cells by interphase fluorescence in situ hybridization and competitive PCR", TRANSFUSION, 41(1), 2001, pp. 111-116
47. Walsh, K; Alexander, GJM
    Update on chronic viral hepatitis
    POSTGRADUATE MEDICAL JOURNAL
    
    K. Walsh e G.J.M. Alexander, "Update on chronic viral hepatitis", POSTG MED J, 77(910), 2001, pp. 498-505
48. Xiang, JH; Wunschmann, S; Diekema, DJ; Klinzman, D; Patrick, KD; George, SL; Stapleton, JT
    Effect of coinfection with GB virus C on survival among patients with HIV infection.
    NEW ENGLAND JOURNAL OF MEDICINE
    
    J.H. Xiang et al., "Effect of coinfection with GB virus C on survival among patients with HIV infection.", N ENG J MED, 345(10), 2001, pp. 707-714
49. Hanrotel, C; Toupance, O; Lavaud, S; Thiefin, G; Brodard, V; Ingrand, D; Diebold, MD; Wynckel, A; Chanard, J
    Virological and histological responses to one year alpha-interferon-2a in hemodialyzed patients with chronic hepatitis C
    NEPHRON
    
    C. Hanrotel et al., "Virological and histological responses to one year alpha-interferon-2a in hemodialyzed patients with chronic hepatitis C", NEPHRON, 88(2), 2001, pp. 120-126
50. Torre-Cisneros, J; Rivero, A
    Management of chronic hepatitis C infection in patients infected with the human immunodeficiency virus: from what we know to what we ignore
    MEDICINA CLINICA
    
    J. Torre-Cisneros e A. Rivero, "Management of chronic hepatitis C infection in patients infected with the human immunodeficiency virus: from what we know to what we ignore", MED CLIN, 116(20), 2001, pp. 775-778
51. Cabot, B; Martell, M; Esteban, JI; Piron, M; Otero, T; Esteban, R; Guardia, J; Gomez, J
    Longitudinal evaluation of the structure of replicating and circulating hepatitis C virus quasispecies in nonprogressive chronic hepatitis C patients
    JOURNAL OF VIROLOGY
    
    B. Cabot et al., "Longitudinal evaluation of the structure of replicating and circulating hepatitis C virus quasispecies in nonprogressive chronic hepatitis C patients", J VIROLOGY, 75(24), 2001, pp. 12005-12013
52. Polakos, NK; Drane, D; Cox, J; Ng, P; Selby, MJ; Chien, D; O'Hagan, DT; Houghton, M; Paliard, X
    Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine
    JOURNAL OF IMMUNOLOGY
    
    N.K. Polakos et al., "Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine", J IMMUNOL, 166(5), 2001, pp. 3589-3598
53. Booth, JCL; O'Grady, J; Neuberger, J
    Clinical guidelines on the management of hepatitis C
    GUT
    
    J.C.L. Booth et al., "Clinical guidelines on the management of hepatitis C", GUT, 49, 2001, pp. I1-I21
54. Lok, AS; Heathcote, EJ; Hoofnagle, JH
    Management of hepatitis B: 2000 - Summary of a workshop
    GASTROENTEROLOGY
    
    A.S. Lok et al., "Management of hepatitis B: 2000 - Summary of a workshop", GASTROENTY, 120(7), 2001, pp. 1828-1853
55. Bacon, BR
    Hemochromatosis: Diagnosis and management
    GASTROENTEROLOGY
    
    B.R. Bacon, "Hemochromatosis: Diagnosis and management", GASTROENTY, 120(3), 2001, pp. 718-725
56. Ugurel, S; Rebmann, V; Ferrone, S; Tilgen, W; Grosse-Wilde, H; Reinhold, U
    Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy
    CANCER
    
    S. Ugurel et al., "Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy", CANCER, 92(2), 2001, pp. 369-376
57. Hall, GW
    Kasabach-Merritt syndrome: Pathogenesis and management
    BRITISH JOURNAL OF HAEMATOLOGY
    
    G.W. Hall, "Kasabach-Merritt syndrome: Pathogenesis and management", BR J HAEM, 112(4), 2001, pp. 851-862
58. Kvasnicka, HM; Thiele, J; Schmitt-Graeff, A; Diehl, V; Zankovich, R; Niederle, N; Leder, LD; Schaefer, HE
    Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia - a multicentre study on 495 patients
    BRITISH JOURNAL OF HAEMATOLOGY
    
    H.M. Kvasnicka et al., "Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia - a multicentre study on 495 patients", BR J HAEM, 112(3), 2001, pp. 727-739
59. Olavarria, E; Kanfer, E; Szydlo, R; Kaeda, J; Rezvani, K; Cwynarski, K; Pocock, C; Dazzi, F; Craddock, C; Apperley, JF; Cross, NCP; Goldman, JM
    Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia
    BLOOD
    
    E. Olavarria et al., "Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia", BLOOD, 97(6), 2001, pp. 1560-1565
60. Tsubota, A; Arase, Y; Saitoh, S; Kobayashi, M; Suzuki, Y; Suzuki, F; Chayama, K; Murashima, N; Ikeda, K; Kobayashi, M; Kumada, H
    Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: A preliminary study
    AMERICAN JOURNAL OF GASTROENTEROLOGY
    
    A. Tsubota et al., "Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: A preliminary study", AM J GASTRO, 96(2), 2001, pp. 557-562
61. Bain, VG
    Effect of HCV viral dynamics on treatment design: Lessons learned from HIV
    AMERICAN JOURNAL OF GASTROENTEROLOGY
    
    V.G. Bain, "Effect of HCV viral dynamics on treatment design: Lessons learned from HIV", AM J GASTRO, 96(10), 2001, pp. 2818-2828
62. Peoc'h, K; Dubel, L; Chazouilleres, O; Ocwieja, T; Duron, F; Poupon, R; Johanet, C
    Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus - Related infection
    AMERICAN JOURNAL OF GASTROENTEROLOGY
    
    K. Peoc'h et al., "Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus - Related infection", AM J GASTRO, 96(10), 2001, pp. 2978-2983
63. Riley, TR; Bhatti, AM
    Preventive strategies in chronic liver disease: Part I. Alcohol, vaccines,toxic medications and supplements, diet and exercise
    AMERICAN FAMILY PHYSICIAN
    
    T.R. Riley e A.M. Bhatti, "Preventive strategies in chronic liver disease: Part I. Alcohol, vaccines,toxic medications and supplements, diet and exercise", AM FAM PHYS, 64(9), 2001, pp. 1555-1560
64. Hadziyannis, SJ; Vassilopoulos, D
    Complex management issues: management of HCV in the atypical patient
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    S.J. Hadziyannis e D. Vassilopoulos, "Complex management issues: management of HCV in the atypical patient", BEST PR RES, 14(2), 2000, pp. 277-291
65. Crosbie, OM; Alexander, GJM
    Liver transplantation for hepatitis C virus related cirrhosis
    BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    
    O.M. Crosbie e G.J.M. Alexander, "Liver transplantation for hepatitis C virus related cirrhosis", BEST PR RES, 14(2), 2000, pp. 307-325
66. Nadir, A; Amin, A; Chalisa, N; van Thiel, DH
    Retinal vein thrombosis associated with chronic hepatitis C: a case seriesand review of the literature
    JOURNAL OF VIRAL HEPATITIS
    
    A. Nadir et al., "Retinal vein thrombosis associated with chronic hepatitis C: a case seriesand review of the literature", J VIRAL HEP, 7(6), 2000, pp. 466-470
67. Trepo, C
    Genotype and viral load as prognostic indicators in the treatment of hepatitis C
    JOURNAL OF VIRAL HEPATITIS
    
    C. Trepo, "Genotype and viral load as prognostic indicators in the treatment of hepatitis C", J VIRAL HEP, 7(4), 2000, pp. 250-257
68. Kondili, LA; Taliani, G; Tosti, ME; De Bac, C; Pasquazzi, C; Mele, A
    Methodological issues in papers on IFN therapy: time for reappraisal
    JOURNAL OF VIRAL HEPATITIS
    
    L.A. Kondili et al., "Methodological issues in papers on IFN therapy: time for reappraisal", J VIRAL HEP, 7(3), 2000, pp. 184-195
69. Meijer, K; Smid, WM; Van der Meer, J
    Treatment of chronic hepatitis C in haemophilia patients
    HAEMOPHILIA
    
    K. Meijer et al., "Treatment of chronic hepatitis C in haemophilia patients", HAEMOPHILIA, 6(6), 2000, pp. 605-613
70. Tran, TX; Day, JA; Eskin, TA; Carney, PR; Maria, BL
    Rasmussen's syndrome - Aetiology, clinical features and treatment options
    CNS DRUGS
    
    T.X. Tran et al., "Rasmussen's syndrome - Aetiology, clinical features and treatment options", CNS DRUGS, 14(5), 2000, pp. 343-354
71. Wickramasinghe, SN
    Congenital dyserythropoietic anemias
    CURRENT OPINION IN HEMATOLOGY
    
    S.N. Wickramasinghe, "Congenital dyserythropoietic anemias", CURR OPIN H, 7(2), 2000, pp. 71-78
72. Sulkowski, MS; Mast, EE; Seeff, LB; Thomas, DL
    Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus
    CLINICAL INFECTIOUS DISEASES
    
    M.S. Sulkowski et al., "Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus", CLIN INF D, 30, 2000, pp. S77-S84
73. Lee, HM; Yoon, GS; Min, KS; Jung, YW; Lee, YS; Suh, DJ; Yu, ES
    Fibrosing cholestatic hepatitis: A report of three cases
    JOURNAL OF KOREAN MEDICAL SCIENCE
    
    H.M. Lee et al., "Fibrosing cholestatic hepatitis: A report of three cases", J KOR MED S, 15(1), 2000, pp. 111-114
74. Lechner, F; Sullivan, J; Spiegel, H; Nixon, DF; Ferrari, B; Davis, A; Borkowsky, B; Pollack, H; Barnes, E; Dusheiko, G; Klenerman, P
    Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    
    F. Lechner et al., "Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers", PHI T ROY B, 355(1400), 2000, pp. 1085-1092
75. Dalekos, GN; Kistis, KG; Boumba, DS; Voulgari, P; Zervou, EK; Drosos, AA; Tsianos, EV
    Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    
    G.N. Dalekos et al., "Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to anti-phospholipid syndrome", EUR J GASTR, 12(1), 2000, pp. 67-74
76. Kraus, I; Vitezic, D
    Anosmia induced with alpha interferon in a patient with chronic hepatitis C
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    
    I. Kraus e D. Vitezic, "Anosmia induced with alpha interferon in a patient with chronic hepatitis C", INT J CL PH, 38(7), 2000, pp. 360-361
77. Kasahara, A
    Treatment strategies for chronic hepatitis C virus infection
    JOURNAL OF GASTROENTEROLOGY
    
    A. Kasahara, "Treatment strategies for chronic hepatitis C virus infection", J GASTRO, 35(6), 2000, pp. 411-423
78. Hehlmann, R; Hochhaus, A; Berger, U; Reiter, A
    Current trends in the management of chronic myelogenous leukemia
    ANNALS OF HEMATOLOGY
    
    R. Hehlmann et al., "Current trends in the management of chronic myelogenous leukemia", ANN HEMATOL, 79(7), 2000, pp. 345-354
79. Prestileo, T; Mazzola, G; Di Lorenzo, F; Colletti, P; Vitale, F; Ferraro, D; Di Stefano, R; Camma, C; Craxi, A
    Response-adjusted alpha-interferon therapy for chronic hepatitis C in HIV-infected patients
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    
    T. Prestileo et al., "Response-adjusted alpha-interferon therapy for chronic hepatitis C in HIV-infected patients", INT J ANT A, 16(3), 2000, pp. 373-378
80. Anthoney, DA; Bone, I; Evans, TRJ
    Inflammatory demyelinating polyneuropathy: A complication of immunotherapyin malignant melanoma
    ANNALS OF ONCOLOGY
    
    D.A. Anthoney et al., "Inflammatory demyelinating polyneuropathy: A complication of immunotherapyin malignant melanoma", ANN ONCOL, 11(9), 2000, pp. 1197-1200
81. Leyssen, P; De Clercq, E; Neyts, J
    Perspectives for the treatment of infections with Flaviviridae
    CLINICAL MICROBIOLOGY REVIEWS
    
    P. Leyssen et al., "Perspectives for the treatment of infections with Flaviviridae", CLIN MICROB, 13(1), 2000, pp. 67
82. Cheney, CP; Chopra, S; Graham, C
    Hepatitis C
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    
    C.P. Cheney et al., "Hepatitis C", INF DIS CL, 14(3), 2000, pp. 633
83. Hochhaus, A; Weisser, A; La Rosee, P; Emig, M; Muller, MC; Saussele, S; Reiter, A; Kuhn, C; Berger, U; Hehlmann, R; Cross, NCP
    Detection and quantification of residual disease in chronic myelogenous leukemia
    LEUKEMIA
    
    A. Hochhaus et al., "Detection and quantification of residual disease in chronic myelogenous leukemia", LEUKEMIA, 14(6), 2000, pp. 998-1005
84. Gutfreund, KS; Bain, VG
    Chronic viral hepatitis C: management update
    CANADIAN MEDICAL ASSOCIATION JOURNAL
    
    K.S. Gutfreund e V.G. Bain, "Chronic viral hepatitis C: management update", CAN MED A J, 162(6), 2000, pp. 827-833
85. Merican, I
    Treatment of chronic hepatitis B virus infection in special groups of patients: decompensated cirrhosis, immunosuppressed and paediatric patients
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    
    I. Merican, "Treatment of chronic hepatitis B virus infection in special groups of patients: decompensated cirrhosis, immunosuppressed and paediatric patients", J GASTR HEP, 15, 2000, pp. E71-E78
86. Chutaputti, A
    Adverse effects and other safety aspects of the hepatitis C antivirals
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    
    A. Chutaputti, "Adverse effects and other safety aspects of the hepatitis C antivirals", J GASTR HEP, 15, 2000, pp. E156-E163
87. Kantarjian, HM; Talpaz, M; Smith, TL; Cortes, J; Giles, FJ; Rios, MB; Mallard, S; Gajewski, A; Murgo, A; Cheson, B; O'Brien, S
    Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemia
    JOURNAL OF CLINICAL ONCOLOGY
    
    H.M. Kantarjian et al., "Homoharringtonine and low-dose cytarabine in the management of late chronic-phase chronic myelogenous leukemia", J CL ONCOL, 18(20), 2000, pp. 3513-3521
88. Asselah, T; Martinot, M; Boyer, N; Marcellin, P
    Genetic variability of hepatitis c virus: clinical implications
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    
    T. Asselah et al., "Genetic variability of hepatitis c virus: clinical implications", GASTRO CL B, 24(2), 2000, pp. 175-184
89. Loubiere, S; Rotily, M; Moatti, JP
    Economic assessment of hepatitis C treatments
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    
    S. Loubiere et al., "Economic assessment of hepatitis C treatments", GASTRO CL B, 24(11), 2000, pp. 1047-1051
90. Lu, M; Kruppenbacher, J; Roggendorf, M
    The importance of the quasispecies nature of hepatitis C virus (HCV) for the evolution of HCV populations in patients: study on a single source outbreak of HCV infection
    ARCHIVES OF VIROLOGY
    
    M. Lu et al., "The importance of the quasispecies nature of hepatitis C virus (HCV) for the evolution of HCV populations in patients: study on a single source outbreak of HCV infection", ARCH VIROL, 145(10), 2000, pp. 2201-2210
91. Corsetti, MT; Lerma, E; Dejana, A; Cavaliere, M; Figari, O; Vassallo, F; Abate, M; Luchetti, S; Piaggio, G; Parodi, C; Pira, GL; Manca, F; Carella, AM
    Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft
    EXPERIMENTAL HEMATOLOGY
    
    M.T. Corsetti et al., "Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft", EXP HEMATOL, 28(1), 2000, pp. 104-111
92. Fujisawa, T; Komatsu, H; Inui, A; Sogo, T; Miyagawa, Y; Fujitsuka, S; Sekine, I; Kosugi, T; Inui, M
    Long-term outcome of chronic hepatitis B in adolescents or young adults infollow-up from childhood
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
    
    T. Fujisawa et al., "Long-term outcome of chronic hepatitis B in adolescents or young adults infollow-up from childhood", J PED GASTR, 30(2), 2000, pp. 201-206
93. Bernard, PH; Le Bail, B; Rullier, A; Trimoulet, P; Neau-Cransac, M; Balabaud, C; Bioulac-Sage, P
    Recurrence and accelerated progression of hepatitis C following liver transplantation
    SEMINARS IN LIVER DISEASE
    
    P.H. Bernard et al., "Recurrence and accelerated progression of hepatitis C following liver transplantation", SEM LIV DIS, 20(4), 2000, pp. 533-538
94. Rehermann, B
    Interaction between the hepatitis C virus and the immune system
    SEMINARS IN LIVER DISEASE
    
    B. Rehermann, "Interaction between the hepatitis C virus and the immune system", SEM LIV DIS, 20(2), 2000, pp. 127-141
95. Carithers, RL; Marquardt, A; Gretch, DR
    Diagnostic testing for hepatitis C
    SEMINARS IN LIVER DISEASE
    
    R.L. Carithers et al., "Diagnostic testing for hepatitis C", SEM LIV DIS, 20(2), 2000, pp. 159-171
96. Layden, TJ; Mika, B; Wiley, TE
    Hepatitis C kinetics: Mathematical modeling of viral response to therapy
    SEMINARS IN LIVER DISEASE
    
    T.J. Layden et al., "Hepatitis C kinetics: Mathematical modeling of viral response to therapy", SEM LIV DIS, 20(2), 2000, pp. 173-183
97. Heathcote, J
    Antiviral therapy for patients with chronic hepatitis C
    SEMINARS IN LIVER DISEASE
    
    J. Heathcote, "Antiviral therapy for patients with chronic hepatitis C", SEM LIV DIS, 20(2), 2000, pp. 185-199
98. Farci, P; Purcell, RH
    Clinical significance of hepatitis C virus genotypes and quasispecies
    SEMINARS IN LIVER DISEASE
    
    P. Farci e R.H. Purcell, "Clinical significance of hepatitis C virus genotypes and quasispecies", SEM LIV DIS, 20(1), 2000, pp. 103-126
99. Jefferson, JA; Johnson, RJ
    Treatment of hepatitis C-associated glomerular disease
    SEMINARS IN NEPHROLOGY
    
    J.A. Jefferson e R.J. Johnson, "Treatment of hepatitis C-associated glomerular disease", SEM NEPHROL, 20(3), 2000, pp. 286-292
100. Pawlotsky, JM
     Hepatitis C virus resistance to antiviral therapy
     HEPATOLOGY
     
     J.M. Pawlotsky, "Hepatitis C virus resistance to antiviral therapy", HEPATOLOGY, 32(5), 2000, pp. 889-896